New combo attack on lung Cancer's spread to the brain
NCT ID NCT07443397
Summary
This study is testing whether adding a drug called anlotinib to standard whole-brain radiation therapy works better than radiation alone for people with small cell lung cancer that has spread to the brain. The goal is to better control the cancer in the brain and help patients live longer. Researchers will also check blood samples to see if they can predict who will benefit most from this combination treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WHOLE-BRAIN RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College
RECRUITINGBeijing, Beijing Municipality, 100004, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.